LURASIDONE HCL vs PALIPERIDONE

Compare LURASIDONE HCL (Lurasidone HCL) and PALIPERIDONE (Paliperidone) — clinical data, side effects, and patient experiences.

LURASIDONE HCL

Lurasidone HCL · Atypical Antipsychotic

How it works

Other agent

Approved for

See full prescribing information

OralTablet

PALIPERIDONE

Paliperidone, Invega · Atypical Antipsychotic

How it works

12.1 Mechanism of Action Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone in schizophrenia is unclear. However, the drug's therap...

Approved for

as well as one maintenance trial in adults.

OralTablet

Quick Comparison

LURASIDONE HCLPALIPERIDONE

Drug Class

Atypical Antipsychotic

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LURASIDONE HCL

Drug Not Working

>10%

Anxiety

1-10%

Depression

1-10%

Weight Gain

1-10%

Drowsiness

1-10%

Nausea

1-10%

Insomnia

1-10%

Fatigue

1-10%

PALIPERIDONE

Drug Not Working

>10%

Weight Gain

1-10%

Condition Worsened

0.1-1%

FDA Warnings

LURASIDONE HCL

1 Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1
7-times the risk of death in placebo-treated patients
Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4

PALIPERIDONE

5 WARNINGS AND PRECAUTIONS Cerebrovascular Adverse Reactions: An increased incidence of cerebrovascular adverse reactions (e
, stroke, transient ischemic attack, including fatalities) has been seen in elderly patients with dementia-related psychoses treated with atypical antipsychotics
3) QT Prolongation: Increase in QT interval, avoid use with drugs that also increase QT interval and in patients with risk factors for prolonged QT interval
5) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk

Clinical Trial Data

No head-to-head clinical studies found for LURASIDONE HCL vs PALIPERIDONE.

LURASIDONE HCL vs PALIPERIDONE: What You Should Know

Key Differences

Both LURASIDONE HCL and PALIPERIDONE belong to the Atypical Antipsychotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

LURASIDONE HCL carries 4 FDA warnings. PALIPERIDONE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

OLANZAPINE vs PALIPERIDONE→ARIPIPRAZOLE vs PALIPERIDONE→PALIPERIDONE vs RISPERIDONE→ARIPIPRAZOLE ORAL vs PALIPERIDONE→CLOZAPINE vs PALIPERIDONE→ASENAPINE vs PALIPERIDONE→

Loading comparison data...

LURASIDONE HCL vs PALIPERIDONE

Compare LURASIDONE HCL (Lurasidone HCL) and PALIPERIDONE (Paliperidone) — clinical data, side effects, and patient experiences.

LURASIDONE HCL

Lurasidone HCL · Atypical Antipsychotic

How it works

Other agent

Approved for

See full prescribing information

OralTablet

PALIPERIDONE

Paliperidone, Invega · Atypical Antipsychotic

How it works

12.1 Mechanism of Action Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone in schizophrenia is unclear. However, the drug's therap...

Approved for

as well as one maintenance trial in adults.

OralTablet

Quick Comparison

LURASIDONE HCLPALIPERIDONE

Drug Class

Atypical Antipsychotic

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LURASIDONE HCL

Drug Not Working

>10%

Anxiety

1-10%

Depression

1-10%

Weight Gain

1-10%

Drowsiness

1-10%

Nausea

1-10%

Insomnia

1-10%

Fatigue

1-10%

PALIPERIDONE

Drug Not Working

>10%

Weight Gain

1-10%

Condition Worsened

0.1-1%

FDA Warnings

LURASIDONE HCL

1 Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1
7-times the risk of death in placebo-treated patients
Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4

PALIPERIDONE

5 WARNINGS AND PRECAUTIONS Cerebrovascular Adverse Reactions: An increased incidence of cerebrovascular adverse reactions (e
, stroke, transient ischemic attack, including fatalities) has been seen in elderly patients with dementia-related psychoses treated with atypical antipsychotics
3) QT Prolongation: Increase in QT interval, avoid use with drugs that also increase QT interval and in patients with risk factors for prolonged QT interval
5) Metabolic Changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk

Clinical Trial Data

No head-to-head clinical studies found for LURASIDONE HCL vs PALIPERIDONE.

LURASIDONE HCL vs PALIPERIDONE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.